BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12538424)

  • 1. Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
    Smieja M; Gnarpe J; Lonn E; Gnarpe H; Olsson G; Yi Q; Dzavik V; McQueen M; Yusuf S;
    Circulation; 2003 Jan; 107(2):251-7. PubMed ID: 12538424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study.
    Haider AW; Wilson PW; Larson MG; Evans JC; Michelson EL; Wolf PA; O'Donnell CJ; Levy D
    J Am Coll Cardiol; 2002 Oct; 40(8):1408-13. PubMed ID: 12392829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of pathogen burden and risk of myocardial infarction or death.
    Zhu J; Nieto FJ; Horne BD; Anderson JL; Muhlestein JB; Epstein SE
    Circulation; 2001 Jan; 103(1):45-51. PubMed ID: 11136684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipid profiles poorly correlate with Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus seropositivity in prospectively followed-up healthy children.
    Volanen I; Raitakari OT; Vainionpää R; Arffman M; Aarnisalo J; Anglé S; Kallio K; Simell O
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):827-32. PubMed ID: 15692096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Previous exposure to Chlamydia pneumoniae, Helicobacter pylori and other infections in Canadian patients with ischemic heart disease.
    Smieja M; Cronin L; Levine M; Goldsmith CH; Yusuf S; Mahony JB
    Can J Cardiol; 2001 Mar; 17(3):270-6. PubMed ID: 11264559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease.
    Muhlestein JB; Horne BD; Carlquist JF; Madsen TE; Bair TL; Pearson RR; Anderson JL
    Circulation; 2000 Oct; 102(16):1917-23. PubMed ID: 11034939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological evidence of infections and Type 2 diabetes: the MultiEthnic Study of Atherosclerosis.
    Lutsey PL; Pankow JS; Bertoni AG; Szklo M; Folsom AR
    Diabet Med; 2009 Feb; 26(2):149-52. PubMed ID: 19236617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological markers of Chlamydia pneumoniae, cytomegalovirus and Helicobacter pylori infection in diabetic and non-diabetic patients with unstable angina pectoris.
    Altannavch Ts; Roubalová K; Broz J; Hrubá D; Andĕl M
    Cent Eur J Public Health; 2003 Jun; 11(2):102-6. PubMed ID: 12884557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and persistence of antibodies to herpes viruses, Chlamydia pneumoniae and Helicobacter pylori in Alaskan Eskimos: the GOCADAN Study.
    Zhu J; Davidson M; Leinonen M; Saikku P; Gaydos CA; Canos DA; Gutman KA; Howard BV; Epstein SE;
    Clin Microbiol Infect; 2006 Feb; 12(2):118-22. PubMed ID: 16441448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women.
    Ridker PM; Hennekens CH; Buring JE; Kundsin R; Shih J
    Ann Intern Med; 1999 Oct; 131(8):573-7. PubMed ID: 10523217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, infection and cardiovascular events in chronic hemodialysis patients: a prospective study.
    Bellomo G; Lippi G; Saronio P; Reboldi G; Verdura C; Timio F; Timio M
    J Nephrol; 2003; 16(2):245-51. PubMed ID: 12768072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socioeconomic and psychosocial gradients in cardiovascular pathogen burden and immune response: the multi-ethnic study of atherosclerosis.
    Aiello AE; Diez-Roux A; Noone AM; Ranjit N; Cushman M; Tsai MY; Szklo M
    Brain Behav Immun; 2009 Jul; 23(5):663-71. PubMed ID: 19150399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease.
    Al-Ghamdi A; Jiman-Fatani AA; El-Banna H
    Pak J Pharm Sci; 2011 Apr; 24(2):95-101. PubMed ID: 21454155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis.
    Mayr M; Kiechl S; Willeit J; Wick G; Xu Q
    Circulation; 2000 Aug; 102(8):833-9. PubMed ID: 10952949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a link between seropositivity to Helicobacter pylori and hepatitis A virus? A systematic review.
    BinSaeed AA
    Int J Infect Dis; 2010 Jul; 14(7):e567-71. PubMed ID: 20060352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: Results from a population-based case-control study.
    Heuschmann PU; Neureiter D; Gesslein M; Craiovan B; Maass M; Faller G; Beck G; Neundoerfer B; Kolominsky-Rabas PL
    Stroke; 2001 Oct; 32(10):2253-8. PubMed ID: 11588309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between infectious burden and carotid atherosclerosis in Japanese patients.
    Hagiwara N; Toyoda K; Inoue T; Shimada H; Ibayashi S; Iida M; Okada Y
    J Stroke Cerebrovasc Dis; 2007; 16(4):145-52. PubMed ID: 17689410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of infectious burden on progression of carotid atherosclerosis.
    Espinola-Klein C; Rupprecht HJ; Blankenberg S; Bickel C; Kopp H; Victor A; Hafner G; Prellwitz W; Schlumberger W; Meyer J
    Stroke; 2002 Nov; 33(11):2581-6. PubMed ID: 12411646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women.
    Bloemenkamp DG; Mali WP; Tanis BC; Rosendaal FR; van den Bosch MA; Kemmeren JM; Algra A; Ossewaarde JM; Visseren FL; van Loon AM; van der Graaf Y
    Atherosclerosis; 2002 Jul; 163(1):149-56. PubMed ID: 12048133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile.
    Hoffmeister A; Rothenbacher D; Bode G; Persson K; März W; Nauck MA; Brenner H; Hombach V; Koenig W
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):427-32. PubMed ID: 11231924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.